Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Sanara MedTech Inc.NASDAQ: SMTI

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income turns positive

Q1 FY2026 net income was $458.6K, compared with -$3.53M a year earlier. Trailing-twelve-month net income was -$23.67M. Over 3 fiscal years it compounded at +50.6% a year.

Context

  • Net income amounted to 26.8% of revenue in FY2025, up 15.4 pp from a year earlier.
  • Net income grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of $646.73K (+102.3%) for the fiscal year ending Dec 2026, a slowdown from the +179.0% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$458.6K+102.0% QoQ
Last fiscal yearDec 2025
-$27.66M+179.0% YoY
LTMMar 2026
-$23.67M+103.8% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+113.0%-89.1%-202.1 pp
1 year+179.0%+102.3%-76.7 pp
3-year CAGR+50.6%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(27.66M) USD
Year-over-year change
-179.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +103.8% is the 4th highest of 10, against a peer median of +21.1%.
  • Net income amounts to 22.0% of revenue for SMTI, versus a peer median of 6.9%.
SMTI Competitors
Net Income for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$166.12M USD-770.3%+15.0%2895.1%
NEONeoGenomics, Inc.LTM Jun 2026$51.88M USD-50.1%-9.2%6.8%
HITIHigh Tide Inc.LTM Apr 2026CA$46.43M CAD+388.6%-10.1%6.9%
SGHTSight Sciences, Inc.LTM Mar 2026$37.25M USD-24.6%-23.6%46.8%
SMTISanara MedTech Inc.LTM Mar 2026$23.67M USD+103.8%+50.6%22.0%
STXSStereotaxis, Inc.LTM Mar 2026$21.68M USD-14.5%+5.8%69.5%
XGNExagen Inc.LTM Mar 2026$20.17M USD+30.0%-25.1%29.5%
TBRGTruBridge, Inc.LTM Mar 2026$16.51M USD+191.1%-35.0%4.8%
VMDViemed Healthcare, Inc.LTM Mar 2026$15.16M USD+21.1%+33.9%5.3%
LFMDLifeMD, Inc.LTM Mar 2026$507.37K USD+105.0%—0.2%
Peer median (excluding SMTI) —+21.1%-9.7%6.9%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.99M)(8.09M)(4.44M)(9.91M)(27.66M)
Depreciation & Amortization596.98K2.37M3.68M4.92M28.56M
Deferred Income Tax0(5.84M)000
Stock-Based Compensation2.67M2.7M3.44M4.44M718.71K
Change in Working Capital(1.18M)517.62K(3.28M)(911.72K)(3.84M)
Accounts Receivables(774.81K)(2.27M)(1.73M)(4.54M)4.03M
Inventory(1.15M)(517.27K)(1.55M)1.44M(431.33K)
Accounts Payables99.13K(423.75K)575.15K(471.21K)1.24M
Other Working Capital645.56K3.73M(577.32K)2.66M(8.68M)
Other Non-Cash Items1.1M2.79M(2.64M)1.44M9.02M
Operating Cash Flow(4.81M)(5.55M)(3.25M)(23.78K)6.79M
Capital Expenditures(750.45K)(747.02K)(265.25K)(229.3K)(4.63M)
Acquisitions (Net)0(2.52M)(9.94M)00
Purchases of Investments(4.53M)(250K)0(5.3M)9.48M
Sales of Investments0000(2.96M)
Other Investing Activities(578.59K)(598.45K)650(1.1M)(10.47M)
Investing Cash Flow(5.28M)(3.51M)(10.21M)(6.61M)(8.36M)
Debt Repayment009.69M19.59M0
Common Stock Issued28.94M0911.37K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(642.53K)(627.35K)(958.59K)(2.15M)(8.48M)
Financing Cash Flow28.3M(627.35K)9.64M17.37M(8.48M)
Effect of Forex Changes00000
Net Change in Cash18.2M(9.69M)(3.81M)10.73M(10.03M)
Free Cash Flow(5.56M)(6.3M)(3.51M)(253.08K)2.16M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.